Healthcare & Life Sciences
Radionetics Oncology
United Statesradionetics.com
Radionetics Oncology is a startup based in the United States, most recent round Series A, 1 tracked investor.
activeseries-a
series-a
Stage
2023
Founded
1
Investors
About Radionetics Oncology
Radionetics Oncology is a company founded in 2023 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Radionetics Oncology develops small-molecule radiopharmaceuticals that target G-protein-coupled receptors over-expressed on cancer cells to deliver radioisotopes for diagnostic imaging and radiotherapy.
Explore Radionetics Oncology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.